NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against PACS Group, Inc. (NYSE: PACS) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in PACS, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/pacs-group-inc. Investors have until January 13, 2025, to ask the Court to be appointed to lead t ...

Core Viewpoint - PACS Group, Inc. is under investigation for potential violations of federal securities laws following allegations of fraudulent practices related to Medicare benefits, which significantly impacted its stock price and financial standing [1][3]. Company Overview - PACS Group is one of the largest operators of skilled nursing facilities in the United States, claiming to have a successful turnaround strategy to enhance profitability [2]. Allegations and Impact - A report by Hindenburg Research accused PACS of abusing COVID-era waivers to improperly access Medicare benefits for thousands of patients, which allegedly accounted for over 100% of the company's operating and net income from 2020 to 2023 [3]. - Following the report's release on November 4, 2024, PACS's stock price plummeted by 27.8%, dropping from $42.94 to $31.01 per share within three days [3]. Legal Actions - Bleichmar Fonti & Auld LLP is conducting an investigation into PACS and is encouraging affected investors to seek legal options, emphasizing that representation will be on a contingency fee basis [1][4]. Law Firm Background - Bleichmar Fonti & Auld LLP is recognized as a leading international law firm specializing in securities class actions and has achieved significant recoveries in past cases, including over $900 million from Tesla's Board of Directors [5].

SAN DIEGO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether PACS Group, Inc. (NYSE: PACS) or any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. On November 4, 2024, Hindenburg Research issued a report questioning PACS claims to have discovered a winning ‘turnaround’ formula for transforming poorly performing skilled nursing facilities into “cash ...

NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of PACS Group, Inc. (NYSE: PACS) resulting from allegations that PACS Group may have issued materially misleading business information to the investing public. So What: If you purchased PACS Group securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrang ...

NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into PACS Group, Inc. (NYSE: PACS) for potential violations of the federal securities laws. If you invested in PACS, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/pacs-group-inc. Why Did PACS’s Stock Drop? PACS is one of the largest operators of skilled nursing facilities in the United States. PACS has repeatedly represen ...

NEWTOWN, Pa., Nov. 10, 2024 /PRNewswire/ -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving PACS Group Inc. (NASDAQ: PACS) resulting from allegations of providing misleading business information to the investing public.If you have non-public information that could assist in the PACS Group Inc. investigation or if you are a PACS Group Inc. investor who suffered a loss and would like to learn more, you can provide your information HERE.You can also contact a ...

RADNOR, Pa., Nov. 10, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of PACS Group, Inc. (NYSE: PACS) (“PACS”). On November 4, 2024, Hindenburg Research published a report titled: "PACS Group: How to Become A Billionaire In The Skilled Nursing Industry By Systematically Scamming Taxpayers." Specifically, the report indicated after a 5-month investigation that incl ...

NEW YORK, Nov. 10, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into PACS Group, Inc. (NYSE: PACS) for potential violations of the federal securities laws. If you invested in PACS, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/pacs-group-inc. Why Did PACS's Stock Drop? PACS is one of the largest operators of skilled nursing facilities in the United States. PACS has repeatedly represent ...

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of PACS Group, Inc. due to allegations of materially misleading business information issued by the company [1] Group 1: Investigation and Allegations - PACS Group may have issued misleading information to the investing public, prompting an investigation by Rosen Law Firm [1] - Hindenburg Research published a report alleging that PACS Group's turnaround strategy for skilled nursing facilities involves scamming taxpayer-funded healthcare programs, leading to a significant stock price drop of 27.7% on November 4, 2024 [3] Group 2: Class Action and Compensation - Investors who purchased PACS Group securities may be entitled to compensation through a class action lawsuit, with no out-of-pocket fees due to a contingency fee arrangement [2] - Rosen Law Firm is preparing a class action to seek recovery of investor losses [2] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [4] - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]

Group 1 - The law firm Kessler Topaz Meltzer & Check, LLP is investigating potential violations of federal securities laws on behalf of investors of PACS Group, Inc. (NYSE: PACS) [1] - Hindenburg Research published a report alleging that PACS Group systematically scammed taxpayers by abusing a COVID-era waiver to access Medicare benefits for thousands of patients, which significantly inflated its operating and net income from 2020 to 2023 [2] - Following the report, PACS' stock price dropped 27.8%, from $42.94 per share on November 1, 2024, to $31.01 per share on November 4, 2024 [2]